Difference between revisions of "Main Page Mobile"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
(Created page with "='''HemOnc.org - A Free Hematology/Oncology Reference'''= Created by oncologists as a knowledge base for providers, this site contains reference notes prepared by their peers...")
 
m (Text replacement - "http://hemonc.org" to "https://hemonc.org")
 
(32 intermediate revisions by 3 users not shown)
Line 1: Line 1:
 +
{{DISPLAYTITLE:<span style="display: none"></span>}}
 +
<!--Hides title of page-->
 
='''HemOnc.org - A Free Hematology/Oncology Reference'''=
 
='''HemOnc.org - A Free Hematology/Oncology Reference'''=
  
Created by oncologists as a knowledge base for providers, this site contains reference notes prepared by their peers and allows people to share wisdom and insights from their own clinical experiences for the benefit of allThis shared online notebook will continue to evolve and grow to meet the needs of the community because users such as yourself are able to refine and build upon existing content.
+
'''<big><big>This is an obsolete page which is no longer needed since the software that runs this site now offers better built-in support for mobile/phone/tablet users.  For posterity, this page will remain here for now<br>[https://hemonc.org/w/index.php?title=Main_Page&mobileaction=toggle_view_mobile If you wish to use the mobile version of the site, click here].
 +
</big></big>'''
 +
<center>
 +
{| class="wikitable"
 +
|-
 +
| <div style="background-color: #fee0d1; border: 1px solid #808000; padding: 5px; {{border-radius|16px}}" align="right"><font size="4"><b>{{#ask: [[Regimen::+]] |?Regimen |limit=10000|format=sum}} [[Tutorial#Regimens|regimens]] on HemOnc.org</b></font></div> || <div style="background-color: #deebf6; border: 1px solid #808000; padding: 5px; {{border-radius|16px}}"><font size="4"><b>{{#ask: [[Variant::+]] |?Variant |limit=10000|format=sum}} [[Tutorial#Variants|variants]] on HemOnc.org</b></font></div>
 +
|}
 +
</center>
 +
 
 +
<center><big>'''[[Main Page | Desktop version of the main page]]<br>[[How to add HemOnc.org to your home screen | How to add a HemOnc.org shortcut to your mobile device's home screen]]'''</big></center>
 +
{| class="wikitable" style="text-align:center;" style="color:white; font-size:225%; line-height:1.05em;"
 +
!colspan="2" align="center" style="background-color:#696969"| Quick links to chemotherapy regimens
 +
|-
  
<center><big>'''[[Main Page | Desktop version of the main page]]<br>[[Special:AllPages|Browse our complete index of pages]]'''</big></center>
+
|colspan="2" align="center" style="color:white; background-color:#00008B"| '''Solid tumors'''
{| border="1" style="text-align:center;" style="font-size:200%; line-height:1em;"
+
|-
!colspan="2" align="center" style="background-color:#0066FF"| Quick links to chemotherapy regimens
+
|style="height:50px" |[[Anal cancer]]
 +
|[[Bladder cancer]]
 +
|-
 +
|style="height:50px" |[[Bone sarcoma]]
 +
|[[Breast cancer]]
 +
|-
 +
|style="height:50px" |[[Central nervous system (CNS) cancer]]
 +
|[[Cervical cancer]]
 +
|-
 +
|style="height:50px" |[[Colon cancer]]
 +
|[[Esophageal cancer]]
 +
|-
 +
|style="height:50px" |[[Gastric cancer]]
 +
|[[Germ cell tumors]]
 +
|-
 +
|style="height:50px"|[[Head and neck cancer]]
 +
|[[Hepatobiliary cancer]]
 +
|-
 +
|style="height:50px"|[[Non-small cell lung cancer | Lung cancer, non-small cell]]
 +
|[[Small cell lung cancer | Lung cancer, small cell]]
 +
|-
 +
|style="height:50px" |[[Melanoma]]
 +
|[[Malignant pleural mesothelioma]]
 +
|-
 +
|style="height:50px" |[[Neuroendocrine tumor]]
 +
|[[Basal cell and squamous cell skin cancer | Skin, basal & squamous cancer]]
 +
|-
 +
|style="height:50px"|[[Ovarian cancer]]
 +
|[[Pancreatic cancer]]
 +
|-
 +
|style="height:50px" |[[Penile cancer]]
 +
|[[Prostate cancer]]
 +
|-
 +
|style="height:50px" |[[Rectal cancer]]
 +
|[[Renal cell carcinoma]]
 +
|-
 +
|style="height:50px" |[[Soft tissue sarcoma]]
 +
|[[Testicular cancer]]
 +
|-
 +
|style="height:50px" |[[Thymoma]]
 +
|[[Thyroid cancer]]
 +
|-
 +
|style="height:50px" |[[Unknown primary]]
 +
|[[Endometrial cancer]]
 
|-
 
|-
 
|colspan="2" align="center" style="background-color:#FF0D00"| '''Acute leukemias'''
 
|colspan="2" align="center" style="background-color:#FF0D00"| '''Acute leukemias'''
Line 17: Line 74:
 
|colspan="2" align="center" style="background-color:#FF0D00"| '''Myeloproliferative neoplasms and myelodysplastic syndromes'''
 
|colspan="2" align="center" style="background-color:#FF0D00"| '''Myeloproliferative neoplasms and myelodysplastic syndromes'''
 
|-
 
|-
|style="height:50px" |[[Chronic myelogenous leukemia | Chronic myelogenous leukemia (CML)]]
+
|style="height:50px" |[[Chronic myeloid leukemia | Chronic myelogenous leukemia (CML)]]
 
|[[Chronic myelomonocytic leukemia | Chronic myelomonocytic leukemia (CMML)]]
 
|[[Chronic myelomonocytic leukemia | Chronic myelomonocytic leukemia (CMML)]]
 
|-
 
|-
Line 31: Line 88:
 
|colspan="2" align="center" style="background-color:#FF0D00"| '''Mature B-, T-, and NK-cell neoplasms'''
 
|colspan="2" align="center" style="background-color:#FF0D00"| '''Mature B-, T-, and NK-cell neoplasms'''
 
|-
 
|-
|style="height:50px" |[[Aggressive Non-Hodgkin lymphoma]]
+
|style="height:50px" |[[Anaplastic large cell lymphoma|Anaplastic large cell lymphoma (ALCL)]]
|[[Chronic lymphocytic leukemia (CLL) and Small lymphocytic lymphoma (SLL) | Chronic lymphocytic leukemia (CLL/SLL)]]
+
|[[Burkitt lymphoma|Burkitt lymphoma (BL) or Burkitt-like lymphoma]]
 
|-
 
|-
|style="height:50px" |[[CNS lymphoma]]
+
|style="height:50px" |[[Chronic lymphocytic leukemia | Chronic lymphocytic leukemia (CLL/SLL)]]
|[[Follicular lymphoma]]
+
|[[CNS lymphoma]]
 
|-
 
|-
|style="height:50px" |[[Hairy cell leukemia]]
+
|style="height:50px" |[[Cutaneous T-cell lymphoma|Cutaneous T-cell lymphoma (CTCL)]]
 +
|[[Diffuse large B-cell lymphoma|Diffuse large B-cell lymphoma (DLBCL)]]
 +
|-
 +
|style="height:50px" |[[Extranodal NK- and T-cell lymphoma, nasal type]]
 +
|[[Follicular lymphoma|Follicular lymphoma (FL)]]
 +
|-
 +
|style="height:50px" |[[Hairy cell leukemia|Hairy cell leukemia (HCL)]]
 
|[[HIV-associated lymphoma]]
 
|[[HIV-associated lymphoma]]
 
|-
 
|-
|style="height:50px" |[[Hodgkin lymphoma]]  
+
|style="height:50px" |[[Classical Hodgkin lymphoma|Hodgkin lymphoma (HL)]]  
|[[Hodgkin lymphoma, nodular lymphocyte-predominant]]
+
|[[Hodgkin lymphoma, nodular lymphocyte-predominant|Hodgkin lymphoma, nodular lymphocyte-predominant (NLP-HL)]]
 
|-
 
|-
|style="height:50px" |[[Large granular lymphocytic leukemia]]
+
|style="height:50px" |[[Large granular lymphocytic leukemia|Large granular lymphocytic (LGL) leukemia]]
 
|[[Light-chain (AL) amyloidosis]]
 
|[[Light-chain (AL) amyloidosis]]
 
|-
 
|-
|style="height:50px" |[[Mantle cell lymphoma]]
+
|style="height:50px" |[[Mantle cell lymphoma|Mantle cell lymphoma (MCL)]]
|[[Marginal zone lymphoma]]
+
|[[Marginal zone lymphoma|Marginal zone lymphoma (MZL)]]
 +
|-
 +
|style="height:50px" |[[Mediastinal gray-zone lymphoma|Mediastinal gray-zone lymphoma (MGZL)]]
 +
|[[Multiple myeloma|Multiple myeloma (MM)]]
 +
|-
 +
|style="height:50px" |[[NK- and T-cell lymphoma]]
 +
|[[Peripheral T-cell lymphoma|Peripheral T-cell Lymphoma (PTCL)]]
 
|-
 
|-
|style="height:50px" |[[Multiple myeloma]]
+
|style="height:50px" |[[Primary mediastinal B-cell lymphoma|Primary mediastinal B-cell lymphoma (PMBL)]]
|[[T-cell lymphoma]]
+
|[[Transformed lymphoma|Transformed lymphoma (TL)]]
 
|-
 
|-
 
|style="height:50px" |[[Transplant conditioning regimens]]
 
|style="height:50px" |[[Transplant conditioning regimens]]
|[[Waldenström macroglobulinemia]]
+
|[[Waldenström macroglobulinemia|Waldenström macroglobulinemia (WM/LPL)]]
 
|-
 
|-
 
|colspan="2" align="center" style="background-color:#FF0D00"| '''Other hematology'''
 
|colspan="2" align="center" style="background-color:#FF0D00"| '''Other hematology'''
 
|-
 
|-
 
|style="height:50px" |[[Aplastic anemia]]
 
|style="height:50px" |[[Aplastic anemia]]
|[[Autoimmune thrombocytopenic purpura (ITP)]]
+
|[[Immune thrombocytopenia (ITP)]]
 
|-
 
|-
|style="height:50px" |[[Castleman’s disease]]
+
|style="height:50px" |[[Castleman disease]]
 
|[[Coagulopathies]]
 
|[[Coagulopathies]]
 
|-
 
|-
|style="height:50px" |[[Paroxysmal nocturnal hemoglobinuria (PNH)]]
+
|style="height:50px" |[[Hemophagocytic lymphohistiocytosis (HLH)]]
|[[Venous thromboembolism (VTE)]]
+
|[[Histiocytoses]]
|-
 
|colspan="2" align="center" style="background-color:#0066FF"| '''Solid tumors'''
 
|-
 
|style="height:50px" |[[Anal cancer]]
 
|[[Bladder cancer]]
 
|-
 
|style="height:50px" |[[Bone cancer]]
 
|[[Breast cancer]]
 
 
|-
 
|-
|style="height:50px" |[[Central nervous system (CNS) cancer]]
+
|style="height:50px" |[[Paroxysmal_nocturnal_hemoglobinuria]]
|[[Cervical cancer]]
+
|[[Venous_thromboembolism]]
 
|-
 
|-
|style="height:50px" |[[Colon cancer]]
 
|[[Esophageal cancer]]
 
|-
 
|style="height:50px" |[[Gastric cancer]]
 
|[[Head and neck cancer]]
 
|-
 
|style="height:50px" |[[Hepatobiliary cancer]]
 
|[[Non-small cell lung cancer | Lung cancer, non-small cell]]
 
|-
 
|style="height:50px" |[[Small cell lung cancer | Lung cancer, small cell]]
 
|[[Melanoma]]
 
|-
 
|style="height:50px" |[[Mesothelioma]]
 
|[[Neuroendocrine tumors]]
 
|-
 
|style="height:50px" |[[Basal cell and squamous cell skin cancer | Skin, basal & squamous cancer]]
 
|[[Ovarian cancer]]
 
|-
 
|style="height:50px" |[[Pancreatic cancer]]
 
|[[Penile cancer]]
 
|-
 
|style="height:50px" |[[Prostate cancer]]
 
|[[Rectal cancer]]
 
|-
 
|style="height:50px" |[[Renal cancer]]
 
|[[Sarcoma]]
 
|-
 
|style="height:50px" |[[Testicular cancer]]
 
|[[Thymoma]]
 
|-
 
|style="height:50px" |[[Thyroid cancer]]
 
|[[Unknown primary]]
 
|-
 
|style="height:50px" |[[Uterine cancer]]
 
|-
 
 
|}
 
|}
 +
<br><center><big>'''[[Special:AllPages|Browse our complete index of pages]]'''</big></center>
 
<br><inputbox>
 
<br><inputbox>
 
type=create  
 
type=create  
Line 119: Line 146:
 
break=no  
 
break=no  
 
</inputbox>   
 
</inputbox>   
Any information that one feels would be helpful to other oncology providers is welcome.  Visit [[how to contribute]] for more details.  '''By using this site, you are indicating that you have read and agree with the terms set forth in the [[HemOnc.org_-_A_Hematology_Oncology_Wiki:General_disclaimer|disclaimer]].''' Priorities of this project include:
 
 
#Creating a database of [[Drug index | chemotherapy agents and other medications]].
 
#Creating an index of diseases.
 
#Creating a collection of chemotherapy regimens and references to primary literature (PubMed and direct links to the abstracts/full articles).
 
#[[:Category:Example chemotherapy order sets|Sample order sets]] and examples of supportive medications used with treatment regimens
 
#Aggregating [[External links|useful links]] to existing resources by disease, such as information about prognosis, clinical calculators, staging, and patient resources.
 
 
Additional possibilities for this project may include:
 
#Creating summaries of pivotal clinical trials
 
#Establishing homepages for ongoing clinical trials that contain information and sites of participation
 
#Checklists for common clinical scenarios/diseases
 
#Creating checklists that can be used for patients starting therapy with particular regimens, such as laboratory & imaging (e.g. echocardiogram, PFTs) parameters to monitor and informed consent/discussion of side effects
 
#List of [[ICD-9 codes]]
 
#Being a source of [[reference documents]]
 
#[[Pathology | Pathology references]], including histology images and information about immunohistochemistry and CD markers.
 
  
The field of hematology/oncology is ever-changing, and our hope is that other people will be interested in contributing to make it an increasingly more useful resource.  The rapidly evolving nature of the practice demands a more dynamic medium than existing resources can provide and would benefit from being able to be updated in real-time from virtually any computer with internet access. We believe that the familiar format of a Wiki, made popular by sites such as [http://en.wikipedia.org/wiki/Main_Page Wikipedia], will significantly help ease-of-use and navigation.
+
Created by oncologists as a knowledge base for providers, this site contains reference notes prepared by their peers and allows people to share wisdom and insights from their own clinical experiences for the benefit of all. This shared online notebook will continue to evolve and grow to meet the needs of the community because users such as yourself are able to refine and build upon existing content. Please see the [[Main Page | desktop version of the main page]] for more information about [[Main Page | HemOnc.org]].
  
If you would like to contribute, please create an account in the upper right corner, and send a message to [email protected] so that your account can be set up with the necessary rights. Due to the sensitive nature of the information contained within this site, unverified users will not be allowed to edit articles.
+
[[Category:Obsolete pages]]

Latest revision as of 19:32, 23 June 2024

HemOnc.org - A Free Hematology/Oncology Reference

This is an obsolete page which is no longer needed since the software that runs this site now offers better built-in support for mobile/phone/tablet users. For posterity, this page will remain here for now.
If you wish to use the mobile version of the site, click here.

4,428 regimens on HemOnc.org
6,544 variants on HemOnc.org
Desktop version of the main page
How to add a HemOnc.org shortcut to your mobile device's home screen
Quick links to chemotherapy regimens
Solid tumors
Anal cancer Bladder cancer
Bone sarcoma Breast cancer
Central nervous system (CNS) cancer Cervical cancer
Colon cancer Esophageal cancer
Gastric cancer Germ cell tumors
Head and neck cancer Hepatobiliary cancer
Lung cancer, non-small cell Lung cancer, small cell
Melanoma Malignant pleural mesothelioma
Neuroendocrine tumor Skin, basal & squamous cancer
Ovarian cancer Pancreatic cancer
Penile cancer Prostate cancer
Rectal cancer Renal cell carcinoma
Soft tissue sarcoma Testicular cancer
Thymoma Thyroid cancer
Unknown primary Endometrial cancer
Acute leukemias
Acute lymphocytic leukemia (ALL) Acute myeloid leukemia (AML)
Acute promyelocytic leukemia (APL) Transplant conditioning regimens
Myeloproliferative neoplasms and myelodysplastic syndromes
Chronic myelogenous leukemia (CML) Chronic myelomonocytic leukemia (CMML)
Essential thrombocythemia (ET) Hypereosinophilic syndrome (HES)
Mast cell diseases Myelodysplastic syndrome
Primary & secondary myelofibrosis Polycythemia vera (PV)
Mature B-, T-, and NK-cell neoplasms
Anaplastic large cell lymphoma (ALCL) Burkitt lymphoma (BL) or Burkitt-like lymphoma
Chronic lymphocytic leukemia (CLL/SLL) CNS lymphoma
Cutaneous T-cell lymphoma (CTCL) Diffuse large B-cell lymphoma (DLBCL)
Extranodal NK- and T-cell lymphoma, nasal type Follicular lymphoma (FL)
Hairy cell leukemia (HCL) HIV-associated lymphoma
Hodgkin lymphoma (HL) Hodgkin lymphoma, nodular lymphocyte-predominant (NLP-HL)
Large granular lymphocytic (LGL) leukemia Light-chain (AL) amyloidosis
Mantle cell lymphoma (MCL) Marginal zone lymphoma (MZL)
Mediastinal gray-zone lymphoma (MGZL) Multiple myeloma (MM)
NK- and T-cell lymphoma Peripheral T-cell Lymphoma (PTCL)
Primary mediastinal B-cell lymphoma (PMBL) Transformed lymphoma (TL)
Transplant conditioning regimens Waldenström macroglobulinemia (WM/LPL)
Other hematology
Aplastic anemia Immune thrombocytopenia (ITP)
Castleman disease Coagulopathies
Hemophagocytic lymphohistiocytosis (HLH) Histiocytoses
Paroxysmal_nocturnal_hemoglobinuria Venous_thromboembolism


Browse our complete index of pages


Created by oncologists as a knowledge base for providers, this site contains reference notes prepared by their peers and allows people to share wisdom and insights from their own clinical experiences for the benefit of all. This shared online notebook will continue to evolve and grow to meet the needs of the community because users such as yourself are able to refine and build upon existing content. Please see the desktop version of the main page for more information about HemOnc.org.